NCT03547115 2026-03-17A Study of Voruciclib Alone or in Combination With Venetoclax in Subjects With B-Cell Malignancies or AMLMEI Pharma, Inc.Phase 1 Terminated84 enrolled
NCT03514017 2026-03-02Ibrutinib and PD-1 Blockade in High Risk Lymphocytic LeukemiaH. Lee Moffitt Cancer Center and Research InstitutePhase 2 Terminated5 enrolled 11 charts
NCT03779113 2026-02-18An Open-label, Dose Escalation Trial to Evaluate the Safety and Pharmacokinetics of HMPL-523 in Patients With LymphomaHutchmedPhase 1 Terminated69 enrolled 47 charts